EUVIMED · CrossrefJournal
Eurasian Journal of Medicine and Oncology
ISSN 2587-196X · AccScience Publishing
Latest articles
Chemical characterization and hypothesis‑generating network pharmacology analysis of Shenfu Qiangxin pill
Pfirrmann grading of intervertebral disc degeneration: Morphological assessment, treatment response, and emerging quantitative MRI approaches
Beyond the cancer cell: What the 2026 Hallmarks update means for precision oncology
Bioinformatic identification of a fatty acid metabolism-related gene signature for prognosis prediction and drug sensitivity assessment in osteosarcoma
Mechanosensitive cardiac responses to repeated low-level blast exposure: Mechanisms and cardiovascular consequences
Exploratory analysis of CT-derived radiomic features and adipose tissue distribution in relation to lipid metabolism pathway activity in ovarian serous cystadenocarcinoma
Liquid biopsy-based longitudinal monitoring of copy number variations in six biomarker genes reveals exploratory associations with disease progression and treatment resistance in localized soft tissue sarcomas
An exploratory PET/MR radiomics framework for preoperative prediction of HER2 status and metastatic burden in colorectal cancer
Effect of probiotic formulations on clinical parameters of gingivitis: A systematic review
Dual-phase contrast-enhanced computed tomography radiomics combined with clinical factors for predicting minimal extrathyroidal extension in papillary thyroid microcarcinoma
Baxdrostat for uncontrolled and resistant hypertension: Clinical evidence, regulatory approval, and practical implications
An integrated clinical risk scoring and machine learning framework for risk stratification of hepatocellular carcinoma: Development and real-world clinical validation
Predictors of survival after transarterial radioembolization in patients with hepatocellular carcinoma
Oral adverse drug reactions in precision oncology: A phenotype-first framework for causality, triage, and treatment continuity
Incremental value of needle-trajectory radiomics using publicly available three-dimensional transrectal ultrasound data for detecting core-level clinically significant prostate cancer
Integrated evaluation of uric acid, hs-CRP, and leukocyte count across preeclampsia severity among pregnant women in Al-Ahsa, Saudi Arabia: A cross-sectional study
Targeted therapy resistance in EGFR-mutant non-small cell lung cancer: Roles of MET, Trop-2-directed antibody–drug conjugates, and molecular monitoring
Molecular mechanisms responsible for transglutaminase 2 involvement in the multiple sclerosis etiopathogenesis and its possible use as a neuroinflammation biomarker
The gut microbiome-immune-antioxidant axis: Redox-driven host-microbial crosstalk as a determinant of cancer immunotherapy response
Artificial intelligence in contrast-enhanced mammography: Current evidence, clinical integration, and future perspectives – a narrative review
Artificial intelligence in periodontal disease management: Opportunities and challenges
Electro-assisted delivery of quantum dots: Current advances and perspectives in cancer theranostics
Nucleolin overexpression correlates with poor prognosis and immune checkpoint regulation across various cancer types: Insights from The Cancer Genome Atlas and GTEx analyses
Сirculating DNA markers for assessing antitumor therapy efficacy and monitoring metastatic colorectal cancer
Expression patterns and prognostic value of N6-methyladenosine regulators in esophageal cancer
Effects of redox modulation on postprandial oxy-inflammatory transcriptomic responses in overweight adults with cardiometabolic risk following a Mediterranean diet
Artificial intelligence as a copilot, not autopilot: A framework for responsible integration in pediatric hematology-oncology
Nephroprotective effects of melatonin and Nigella sativa against renal ischemia-reperfusion injury
Integrated transcriptomic analysis and RT-qPCR validation using FFPE patient tissues reveal the role of FOXQ1 and MCM10 in ovarian cancer
Autophagy-related-gene signature predicts survival outcomes and the tumor immune landscape in skin cutaneous melanoma
EUVIMED